Table 4 |
|||
|
Disease severity and medication category |
|||
|
Ulcerative colitis |
Crohn's disease |
Total |
|
|
(N = 27) |
(N = 58) |
N=(84) |
|
|
|
|||
|
Disease Severity |
|||
|
|
|||
|
Mild |
67% |
49% |
55% |
|
|
|||
|
Moderate |
19% |
29% |
26% |
|
|
|||
|
Severe |
4% |
8% |
7% |
|
|
|||
|
unknown |
10% |
14% |
12% |
|
|
|||
|
Medication category |
|||
|
|
|||
|
Immunosuppressant |
19% |
34% |
29% |
|
|
|||
|
Systemic steroids |
26% |
38% |
32% |
|
|
|||
|
Topical steroids |
22% |
31% |
27% |
|
|
|||
|
TNF-alpha-drug (any) |
9% |
4% |
|
|
|
|||
|
Mesalazine (derivative) |
74% |
41% |
58% |
|
|
|||
|
Pieper et al. BMC Health Services Research 2009 9:17 doi:10.1186/1472-6963-9-17 |
|||
